IL2 and neoplasm: In addition, a pre-clinical study comparing CAR T cells secreting different γ-chain-cytokines (IL-2, IL-7, IL-15, and IL-21) found increased anti-tumor activity with all the cytokines tested, but effects were mediated through different mechanisms (208).